From: Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate
 | Sepsis | Nonsepsis | P | ||
---|---|---|---|---|---|
 | Etomidate | No etomidate | Etomidate | No etomidate |  |
 | n = 11 | n = 32 | n = 3 | n = 21 | S, E, E*S |
ACTH, pM | 1.4 (3.1) | 2.4 (2.6) | 1.9 (7.5) | 4.1 (3.9) | 0.37, 0.10, 0.22 |
Cholesterol, mM | 1.3 (0.8) | 1.8 (1.2) | 2.4 (1.8) | 2.8 (1.0) | < 0.001, 0.02, 0.75 |
HDL-cholesterol, mM | 0.40 (0.40) | 0.60 (0.60) | 0.80 (0.80) | 0.90 (0.60) | 0.06, 0.18, 0.17 |
Progesterone, nM | 0.40 (0.90) | 0.50 (0.70) | 1.0 (1.0) | 0.60 (0.70) | 0.55, 0.34, 0.16 |
Corticosterone, nM | 3.4 (4.9) | 3.5 (6.4) | 5.3 (4.6) | 4.0 (7.4) | 0.23, 0.04, 0.64 |
Aldosterone, nM | 1.3 (1.3) | 0.70 (1.3) | 0.50 (0.1) | 1.2 (0.7) | 0.08, 0.13, 0.007 |
17-OH-progesterone, nM | 2.9 (2.8) | 2.6 (1.5) | 3.9 (2.1) | 2.5 (2.4) | 0.48, 0.09, < 0.001 |
11ß-deoxycortisol, nM | 15 (58) | 3.1 (8.3) | 34 (30) | 3.7 (3.3) | 0.003, < 0.001, < 0.001 |
Cortisol, nM | 460 (200) | 500 (221) | 325 (134) | 455 (335) | 0.03, 0.98, 0.04 |
Cortisol/11ß-deoxycortiso | l26 (175) | 157 (352) | 12 (28) | 316 (380) | 0.04, < 0.001, < 0.001 |
Cortisol/ACTH | 209 (340) | 223 (229) | 171 (270) | 109 (80) | 0.07, 0.08, 0.08 |
Cortisol increase, nM | 220 (190) | 298 (315) | 165 (169) | 395 (238) | 0.04, < 0.001, 0.98 |
Cortisol increase < 250 nM | 6 (54) | 14 (44) | 2 (67) | 6 (29) | 0.92, 0.17, 0.43 |
DHEA, μM | 6.1 (4.6) | 6.4 (4.9) | 6.1 (1.8) | 5.9 (4.1) | 0.61, 0.61, 0.44 |
DHEAS, nM | 0.70 (1.4) | 0.48 (0.76) | 0.50 (4.2) | 0.90 (1.1) | 0.39, 0.03, 0.87 |
Androstenedione, nM | 3.8 (8.6) | 2.4 (2.9) | 3.6 (2.8) | 2.8 (2.4) | 0.13, 0.02, 0.60 |